Palisade Bio (PALI) Exchange Rate Effect (2013 - 2021)
Palisade Bio (PALI) reported Exchange Rate Effect of -$1042.0 for Q1 2021, down 50.58% year-over-year from -$2108.4 in Q1 2020, and up 65.21% on a QoQ basis from -$2995.0 in Q4 2020.
Palisade Bio (PALI) has 9 years of Exchange Rate Effect data on file, last reported at -$1042.0 in Q1 2021.
- Quarterly Exchange Rate Effect fell 50.58% year-over-year to -$1042.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$1535.0 (up 79.84% YoY) and the FY2020 annual result came in at -$1185.0, up 80.31% from the prior year.
- Exchange Rate Effect improved to -$1042.0 in Q1 2021 per PALI's latest filing, from -$2995.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2639.0 in Q3 2020 and bottomed at -$6443.0 in Q3 2019.
- The 5-year median for Exchange Rate Effect is -$692.0 (2020), against an average of -$985.53.
- Peak annual rise in Exchange Rate Effect reached 372.28% in 2018, while the deepest fall reached 1320.11% in 2018.
- Tracing PALI's Exchange Rate Effect over 5 years: stood at $816.0 in 2017, then slumped by 412.13% to -$2547.0 in 2018, then soared by 129.05% to $740.0 in 2019, then tumbled by 504.73% to -$2995.0 in 2020, then soared by 65.21% to -$1042.0 in 2021.
- Per Business Quant, the three latest PALI Exchange Rate Effect figures stand at -$1042.0 (Q1 2021), -$2995.0 (Q4 2020), and $2639.0 (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -1,042.00 |
| Mar 31, 2021 | -1,042.00 |
| Dec 31, 2020 | -2,995.00 |
| Dec 31, 2020 | -2,995.00 |
| Sep 30, 2020 | 2,639.00 |
| Sep 30, 2020 | 2,639.00 |
| Jun 30, 2020 | -137.00 |
| Jun 30, 2020 | -137.00 |
| Mar 31, 2020 | -692.00 |
| Mar 31, 2020 | -692.00 |
| Dec 31, 2019 | 740.00 |
| Dec 31, 2019 | 740.00 |
| Sep 30, 2019 | -6,443.00 |
| Sep 30, 2019 | -6,443.00 |
| Jun 30, 2019 | -1,218.00 |
| Jun 30, 2019 | -1,218.00 |
| Mar 31, 2019 | 903.00 |
| Mar 31, 2019 | 903.00 |
| Dec 31, 2018 | -2,547.00 |
| Dec 31, 2018 | -2,547.00 |
| Sep 30, 2018 | -3,342.00 |
| Sep 30, 2018 | -3,342.00 |
| Jun 30, 2018 | -2,542.00 |
| Jun 30, 2018 | -2,542.00 |
| Mar 31, 2018 | 501.00 |
| Mar 31, 2018 | 501.00 |
| Dec 31, 2017 | 816.00 |
| Dec 31, 2017 | 816.00 |
| Sep 30, 2017 | -1,032.00 |
| Sep 30, 2017 | -1,032.00 |
| Jun 30, 2017 | -179.00 |
| Jun 30, 2017 | -179.00 |
| Mar 31, 2017 | -184.00 |
| Mar 31, 2017 | -184.00 |
| Dec 31, 2016 | -1,436.00 |
| Dec 31, 2016 | -1,436.00 |
| Sep 30, 2016 | 865.00 |
| Sep 30, 2016 | 865.00 |
| Jun 30, 2016 | 751.00 |
| Jun 30, 2016 | 751.00 |
| Mar 31, 2016 | -723.00 |
| Mar 31, 2016 | -723.00 |
| Dec 31, 2015 | -2,597.00 |
| Dec 31, 2015 | -2,597.00 |
| Sep 30, 2015 | -1,733.00 |
| Sep 30, 2015 | -1,733.00 |
| Jun 30, 2015 | -194.00 |
| Jun 30, 2015 | -194.00 |
| Mar 31, 2015 | 115.00 |
| Mar 31, 2015 | 115.00 |
| Dec 31, 2014 | -103.00 |
| Dec 31, 2014 | -103.00 |
| Sep 30, 2014 | 23.00 |
| Sep 30, 2014 | 23.00 |
| Jun 30, 2014 | 132.00 |
| Jun 30, 2014 | 132.00 |
| Mar 31, 2014 | -1,035.00 |
| Mar 31, 2014 | -1,035.00 |
| Dec 31, 2013 | 842.00 |
| Dec 31, 2013 | 842.00 |
| Sep 30, 2013 | 5,402.00 |
| Sep 30, 2013 | 5,402.00 |